AI assistant
PFIZER INC — Director's Dealing 2018
Jul 11, 2018
29831_dirs_2018-07-11_bd043360-f999-4d50-8282-586ca0e28d62.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2018-07-01
Reporting Person: GOETTLER MICHAEL (Group President)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 31122.0000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Units SSP | $ | Common Stock (1899.0000) | Direct | ||
| Stock Appreciation Rights | $21.0300 | 2019-02-23 | Common Stock (19290.0000) | Direct | |
| Stock Appreciation Rights | $27.3700 | 2020-02-28 | Common Stock (22852.0000) | Direct | |
| Stock Appreciation Rights | $30.5900 | 2021-02-25 | Common Stock (21552.0000) | Direct | |
| Stock Appreciation Rights | $30.5900 | 2023-02-25 | Common Stock (19260.0000) | Direct | |
| Stock Appreciation Rights | $32.2300 | 2019-02-27 | Common Stock (30017.0000) | Direct | |
| Stock Appreciation Rights | $32.2300 | 2021-02-27 | Common Stock (23907.0000) | Direct | |
| Stock Appreciation Rights | $34.0600 | 2022-02-23 | Common Stock (20292.0000) | Direct | |
| Stock Appreciation Rights | $34.0600 | 2024-02-23 | Common Stock (16846.0000) | Direct | |
| Stock Appreciation Rights | $34.5900 | 2020-02-26 | Common Stock (20129.0000) | Direct | |
| Stock Appreciation Rights | $34.5900 | 2022-02-26 | Common Stock (16779.0000) | Direct | |
| Stock Appreciation Rights | $35.7400 | 2023-02-22 | Common Stock (18061.0000) | Direct | |
| Stock Appreciation Rights | $35.7400 | 2025-02-22 | Common Stock (15099.0000) | Direct |
Footnotes
F1: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
F2: Each unit represents one phantom share of common stock.
F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
F4: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.